EMERGING BIOTECH

Drive Launch Success

Go to market more effectively with a well-orchestrated launch
Increasing competition
+48%
in number of approved drugs since 2018
Unmet expectations
36%
of drugs failed to meet market expectations in the first year
High stakes
70%
of products that miss launch expectations continue to underperform

Pre-commercial guide to launch excellence

Identify the right mix of go-to-market plans and operational capabilities in this pre-commercial roadmap for biopharmas.

Download eBook
¡°With ³Ô¹Ï±¬ÁÏ as our trusted partner, we accelerated launch readiness and equipped new sales, medical, and marketing teams with the digital tools they need.¡±

Christopher Mutz, Chief Commercial Officer & Head of Rare Disease, ANI Pharmaceuticals

Product launch tips and best practices

G1 Therapeutics: The importance of a data-driven launch Watch the video

Oyster Point Pharma: Optimizing KOL engagement Watch the video

Insmed: Blueprint for commercial excellence Watch the video

Launch solutions for emerging biotech

Learn why hundreds of pre-commerial companies rely on ³Ô¹Ï±¬ÁÏ to plan and execute their launch.

³Ô¹Ï±¬ÁÏ Medical Solutions

Unify scientific exchange, content, inquiry management, and real-time intelligence.

³Ô¹Ï±¬ÁÏ Vault CRM Suite

Integrate key commercial applications and processes for more effective field engagement.

³Ô¹Ï±¬ÁÏ Vault PromoMats

Manage the approval, storage, and distribution of promotional content.

³Ô¹Ï±¬ÁÏ OpenData

Support launch with global customer reference data.

³Ô¹Ï±¬ÁÏ Link

Identify and engage the right people with real-time customer intelligence.

³Ô¹Ï±¬ÁÏ Compass

Find more patients and HCPs for launch with patient and prescriber data.

Ready to launch with confidence?